Your browser doesn't support javascript.
loading
Expert consensus on personalized initiation of glucose-lowering therapy in adults with newly diagnosed type 2 diabetes without clinical cardiovascular disease or chronic kidney disease.
Zhang, Fang; Ji, Linong; Hong, Tianpei; Guo, Lixin; Li, Yan; Zhu, Zhiming; Liu, Xingbin; Liu, Fang; Tang, Lizhi; Zhang, Yuwei; Li, Juan; Lü, Qingguo; Tong, Nanwei.
Affiliation
  • Zhang F; Division of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Ji L; Department of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing, China.
  • Hong T; Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing, China.
  • Guo L; Department of Endocrinology, National Center of Gerontology, Beijing Hospital, Beijing, China.
  • Li Y; Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Zhu Z; Department of Hypertension and Endocrinology, Chongqing Institute of Hypertension, Daping Hospital, Army Medical University, Chongqing, China.
  • Liu X; Department of Cardiology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Liu F; Department of Nephrology, Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Tang L; Division of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Zhang Y; Division of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Li J; Division of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Lü Q; Division of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
  • Tong N; Division of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
J Evid Based Med ; 15(2): 168-179, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35715995
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Evid Based Med Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Evid Based Med Year: 2022 Document type: Article